Webinar

Self-study

<10 minutes

Disease Burden and Type 2 Inflammation in EoE

Topic: Gastroenterology – Type 2 inflammation and burden of disease

Tags: Disease burden  Guidelines  Pathophysiology  Video  EoE 

Disease Burden and Type 2 Inflammation in EoE

Gastroenterology and allergy expert examine the connection between type 2 inflammation, EoE pathophysiology and disease burden, and review the latest EoE standard of care.

Play Full Video Including Q&A 

Eosinophilic Esophagitis (EoE): Disease Burden, Diagnosis, and the Role of Type 2 Inflammation.

Arjan J. Bredenoord, MD, PhD

Overview of the significant burden of EoE and the impact of delayed diagnosis on disease progression and patient quality of life.

Jonathan Spergel, MD, PhD

Role of underlying type 2 inflammation in EoE pathophysiology and clinical symptoms and the added burden of coexisting type 2 inflammatory diseases.

Evan S. Dellon, MD, MPH

Current clinical practice guidelines for the treatment of EoE and strategies to help manage the progressive nature of EoE and alleviate patient burden.

MAT-US-2101721 V2 Expiration Date 05/10/2023

Please rotate you device for optimal viewing

Welcome to the ADVENT program website

ADVENT is a medical education program by Sanofi Genzyme and Regeneron. This website is intended only for health care professionals in the US only.

I AM A HEALTHCARE PROVIDER
I AM NOT A HEALTHCARE PROVIDER

ADVENT is a global medical education program by Sanofi Genzyme and Regeneron and is only intended for healthcare providers.

You are leaving the ADVENT program website

Sanofi Genzyme does not review or control the content of non–Sanofi Genzyme websites, and this hyperlink does not constitute an endorsement by Sanofi Genzyme of the site’s content. Sanofi Genzyme’s privacy procedures do not apply to the owners of a non–Sanofi Genzyme website.

LEAVE THIS SITE GO BACK TO ADVENT PROGRAM